BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35282462)

  • 1. Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling.
    Galuppini F; Censi S; Merante Boschin I; Fassan M; Sbaraglia M; Valeri N; Hahne JC; Bertazza L; Munari G; Galasso M; Cascione L; Barollo S; Rugge M; Vianello F; Dei Tos AP; Mian C; Pennelli G
    Front Endocrinol (Lausanne); 2022; 13():834075. PubMed ID: 35282462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyto-Histological Profile of MicroRNAs as Diagnostic Biomarkers in Differentiated Thyroid Carcinomas.
    Matos ML; Pinto M; Alves M; Canberk S; Gonçalves A; Bugalho MJ; Papoila AL; Soares P
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma.
    Sheu SY; Grabellus F; Schwertheim S; Handke S; Worm K; Schmid KW
    Horm Metab Res; 2009 Jun; 41(6):482-7. PubMed ID: 19370505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
    Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
    Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA Deregulation in Papillary Thyroid Cancer and its Relationship With BRAF V600E Mutation.
    Celakovsky P; Kovarikova H; Chrobok V; Mejzlik J; Laco J; Vosmikova H; Chmelarova M; Ryska A
    In Vivo; 2021; 35(1):319-323. PubMed ID: 33402480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
    Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
    Dettmer M; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
    Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the BRAFV600E mutation.
    Huang Y; Liao D; Pan L; Ye R; Li X; Wang S; Ye C; Chen L
    Eur J Endocrinol; 2013 May; 168(5):675-81. PubMed ID: 23416953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF mutation, selected miRNAs and genes expression in primary papillary thyroid carcinomas and local lymph node metastases.
    Kalfert D; Ludvikova M; Pesta M; Hakala T; Dostalova L; Grundmannova H; Windrichova J; Houfkova K; Knizkova T; Ludvik J; Polivka J; Kholova I
    Pathol Res Pract; 2024 Jun; 258():155319. PubMed ID: 38696857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
    Yip L; Kelly L; Shuai Y; Armstrong MJ; Nikiforov YE; Carty SE; Nikiforova MN
    Ann Surg Oncol; 2011 Jul; 18(7):2035-41. PubMed ID: 21537871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations.
    Macerola E; Poma AM; Proietti A; Rago T; Romani R; Vignali P; Ugolini C; Torregrossa L; Basolo A; Santini F; Basolo F
    Endocrine; 2022 Jun; 76(3):677-686. PubMed ID: 35347579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA profiling predicts positive nodal status in papillary thyroid carcinoma in the preoperative setting.
    Napoli F; Rapa I; Mortara U; Massa F; Izzo S; Rigutto A; Zambelli V; Bellevicine C; Troncone G; Papotti M; Volante M
    Cancer Cytopathol; 2022 Sep; 130(9):695-704. PubMed ID: 35500065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF
    Gao Y; Xiang D; Li W; Zheng X; Wang L; Li Z; Chen T
    Front Endocrinol (Lausanne); 2022; 13():843334. PubMed ID: 35651980
    [No Abstract]   [Full Text] [Related]  

  • 14. miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation.
    Chou CK; Chen RF; Chou FF; Chang HW; Chen YJ; Lee YF; Yang KD; Cheng JT; Huang CC; Liu RT
    Thyroid; 2010 May; 20(5):489-94. PubMed ID: 20406109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological features and molecular characteristics of tall cell and hobnail variants of papillary thyroid carcinoma].
    Zhang M; Duan HL; Wang LM; Gao W; Yao YY; Teng LH
    Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1234-1239. PubMed ID: 34719160
    [No Abstract]   [Full Text] [Related]  

  • 16. Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
    Geraldo MV; Nakaya HI; Kimura ET
    Oncotarget; 2017 Feb; 8(6):9597-9607. PubMed ID: 28030816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
    Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
    Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma.
    Swierniak M; Wojcicka A; Czetwertynska M; Stachlewska E; Maciag M; Wiechno W; Gornicka B; Bogdanska M; Koperski L; de la Chapelle A; Jazdzewski K
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1401-9. PubMed ID: 23783103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF mutations are associated with some histological types of papillary thyroid carcinoma.
    Trovisco V; Vieira de Castro I; Soares P; Máximo V; Silva P; Magalhães J; Abrosimov A; Guiu XM; Sobrinho-Simões M
    J Pathol; 2004 Feb; 202(2):247-51. PubMed ID: 14743508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma.
    Teng L; Deng W; Lu J; Zhang J; Ren X; Duan H; Chuai S; Duan F; Gao W; Lu T; Wu H; Liang Z
    Oncotarget; 2017 Mar; 8(13):22023-22033. PubMed ID: 28423545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.